Characterization of the Phosphoproteins and Protein Kinase Activity in mTOR Immunoprecipitates
- 18 November 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 252 (2), 440-444
- https://doi.org/10.1006/bbrc.1998.9671
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Kato Memorial Bioscience Foundation
- Juvenile Diabetes Research Foundation International
- Japan Foundation for Applied Enzymology
- Daiichi Sankyo Foundation of Life Science
This publication has 21 references indexed in Scilit:
- IMMUNOPHARMACOLOGY OF RAPAMYCINAnnual Review of Immunology, 1996
- Control of p70 S6 kinase by kinase activity of FRAP in vivoNature, 1995
- Control of PHAS-I by Insulin in 3T3-L1 AdipocytesPublished by Elsevier ,1995
- RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORsCell, 1994
- A mammalian protein targeted by G1-arresting rapamycin–receptor complexNature, 1994
- Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family.Proceedings of the National Academy of Sciences, 1994
- Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progressionCell, 1993
- Rapamycin-Induced Inhibition of the 70-Kilodalton S6 Protein KinaseScience, 1992
- Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinaseNature, 1992
- Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinasesCell, 1992